PhD Theses from 2015
| NAME | TITLE | PROMOTION YEAR | PROMOTORS |
|---|---|---|---|
| Eva De Smedt | Epigenetic reprogramming of malignant plasma cells: the therapeutic potential of RASSF proteins and G9a/GLP targeting in Multiple Myeloma. | 2021 |
Elke De Bruyne Karin Vanderkerken |
| Christelle Orlando | Novel insights in inherited antithrombin deficiency: from laboratory diagnosis to clinical presentation. | 2021 | Kristin Jochmans |
| Anke Maes |
Exploring the therapeutic potential of targeting mitotic exit in combination with standard of care agents in high grade B cell malignancies |
2019 |
Elke De Bruyne Karin Vanderkerken |
| Sylvia Faict | Exosomal communication in Multiple Myeloma: Friend or Foe?” | 2019 |
Eline Menu Karin Vanderkerken Rik Schots |
| Nathan De Beule |
Bone marrow-induced survival: identifying novel targets in multiple myeloma |
2018 |
Karin Vanderkerken Eline Menu Els Van Valckenborgh Rik Schots |
| Mérédis Favreau | Immune therapy in multiple myeloma: can iNKT cells be targeted? | 2017 |
Eline Menu Karin Vanderkerken Dirk Elewaut Koen Venken |
| Susanne Lub | The role of E3 ubiquitin ligases with a focus on the inhibitor of apoptosis proteins (IAPs) and the anaphase promoting complex/cyclosome (APC/C) in multiple myeloma | 2016 |
Karin Vanderkerken Els Van Valckenborgh |
| Liesbeth Bieghs | The IGF system in multiple myeloma: exploring diagnostic and therapeutic potential | 2016 |
Karin Vanderkerken Elke De Bruyne |
| Kim De Veirman | The role of bone marrow derived bystander cells in the development of multiple myeloma | 2016 |
Karin Vanderkerken Els Van Valckenborgh Ivan Van Riet Eline Menu |
| Jinheng Wang | Exosomal communication in the bone marrow microenvironment: a significant player in multiple myeloma progression | 2016 |
Eline Menu Karin Vanderkerken |
| Ken Maes | The therapeutic and prognostic potential of epigenetic modulating agents in multiple myeloma | 2015 |
Karin Vanderkerken Elke De Bruyne |